In vitro study of the effects of sugammadex on the measurement of serum concentrations of progesterone in premenopausal women – an assay validation study

Not Applicable

• Conditions: pregnancy; contraceptive effectviness; Anaesthesiology - Anaesthetics; Reproductive Health and Childbirth - Contraception

• Registration Number: ACTRN12624000036516
• Lead Sponsor: Wollongong Hospital Anaesthetics Department

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-01-16
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

premenopausal women

Exclusion Criteria

Male participants

- Females <18 years old or >50 years old

- Post-menopausal women

- Incomplete/missing key details in questionnaire form

- On hormonal contraception

- Women who may be pregnant

- Women with bilateral ovariectomy

- Sample A & B progesterone levels below level of assay

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
progesterone concentration [serum progesterone assay single timepoint, immediately after mixing blood sample with sugammadex]

Secondary Outcome Measures

Name	Time	Method
il[Nil Nil]